Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Acquired Diseases
  • Published:

Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery

Abstract

A novel formulation of cationic liposomes containing the novel cytofectin ACHx was used for delivery of an anti-inflammatory cytokine gene, IL-10, to mice with established collagen induced arthritis. A single intraperitoneal injection of human IL-10 expression plasmid complexed with liposomes 2 to 4 days after the onset of arthritis was sufficient to give significant and prolonged amelioration of arthritis for 30 days. Preliminary experiments suggested that the therapeutic effect was IL-10 dose-dependent. The distribution of the human IL-10 DNA after injection was widespread, including the inflamed paws. Human IL-10 mRNA was also detected in the paws 24 h after injection. IL-10 protein was below the level of detection in paws and serum but was detected in some tissues up to 10 days after injection. The target cell of transfection was demonstrated to be the macrophage. These results suggest that systemic therapy with plasmid DNA complexed with cationic liposomes merits further development as an alternative method for anti-inflammatory treatment of arthritis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Staines NA, Wooley PH . Collagen arthritis – what can it teach us? Br J Rheumatol 1994 33: 798–807

    Article  CAS  PubMed  Google Scholar 

  2. Maini RN et al (eds). Oxford Textbook of Rheumatology: Immunopathogenesis of Rheumatoid Arthritis Oxford University Press: Oxford 1993

    Google Scholar 

  3. Kinne RW et al. Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes Arthr Rheum 1995 38: 1777–1790

    Article  CAS  Google Scholar 

  4. van Lent PL et al. In vivo role of phagocytic synovial lining cells in onset of experimental arthritis Am J Pathol 1993 143: 1226–1237

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Di Giovine FS, Nuki G, Duff GW . Tumour necrosis factor in synovial exudates Ann Rheum Dis 1988 47: 768–772

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Miyasaka N et al. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction Arthr Rheum 1988 31: 480–486

    Article  CAS  Google Scholar 

  7. Hirano T et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis Eur J Immunol 1988 18: 1797–1801

    Article  CAS  PubMed  Google Scholar 

  8. Mauri C, Williams RO, Walmsley M, Feldmann M . Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis Eur J Immunol 1996 26: 1511–1518

    Article  CAS  PubMed  Google Scholar 

  9. Takai Y et al. Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis Arthr Rheum 1989 32: 594–600

    Article  CAS  Google Scholar 

  10. Katsikis PD et al. Immunoregulatory role of interleukin 10 in rheumatoid arthritis J Exp Med 1994 179: 1517–1527

    Article  CAS  PubMed  Google Scholar 

  11. Brennan FM et al. Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures Clin Exp Immunol 1990 81: 278–285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Deleuran BW et al. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis Br J Rheumatol 1992 31: 801–809

    Article  CAS  PubMed  Google Scholar 

  13. Firestein GS et al. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium J Immunol 1992 149: 1054–1062

    CAS  PubMed  Google Scholar 

  14. Joosten LA, Helsen MM, van de Loo FA, van den Berg WB . Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra Arthr Rheum 1996 39: 797–809

    Article  CAS  Google Scholar 

  15. Williams RO, Feldmann M, Maini RN . Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci USA 1992 89: 9784–9788

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Elliott MJ et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha Arthr Rheum 1993 36: 1681–1690

    Article  CAS  Google Scholar 

  17. Elliott MJ et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis Lancet 1994 344: 1105–1110

    Article  CAS  PubMed  Google Scholar 

  18. Persson S et al. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats Scand J Immunol 1996 44: 607–614

    Article  CAS  PubMed  Google Scholar 

  19. Walmsley M et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis Arthr Rheum 1996 39: 495–503

    Article  CAS  Google Scholar 

  20. Tanaka Y et al. Effect of IL-10 on collagen-induced arthritis in mice Inflamm Res 1996 45: 283–288

    Article  CAS  PubMed  Google Scholar 

  21. Chernajovsky Y, Feldmann M, Maini RN . Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives Br Med Bull 1995 51: 503–516

    Article  CAS  PubMed  Google Scholar 

  22. Muller Ladner U et al. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective J Immunol 1997 158: 3492–3498

    CAS  PubMed  Google Scholar 

  23. Otani K et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy J Immunol 1996 156: 3558–3562

    CAS  PubMed  Google Scholar 

  24. Hung GL et al. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium Gene Therapy 1994 1: 64–69

    CAS  PubMed  Google Scholar 

  25. Evans CH et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis Hum Gene Ther 1996 7: 1261–1280

    Article  CAS  PubMed  Google Scholar 

  26. Kirsh R, Poste G . Liposome targeting to macrophages: opportunities for treatment of infectious diseases Adv Exp Med Biol 1986 202: 171–184

    Article  CAS  PubMed  Google Scholar 

  27. Oyen WJ et al. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes J Nucl Med 1996 37: 1392–1397

    CAS  PubMed  Google Scholar 

  28. Williams AS, Camilleri JP, Williams BD . Suppression of adjuvant-induced arthritis by liposomally conjugated methotrexate in the rat Br J Rheumatol 1994 33: 530–533

    Article  CAS  PubMed  Google Scholar 

  29. Cooper RG et al. Polyamine analogues of 3-[N-(N′,N′-dimethylaminoethane)carbamoyl]-cholesterol (DC-Chol) as agents for gene delivery Chem Eur J 1998 4: 137–151

    Article  Google Scholar 

  30. Springer T, Galfre G, Secher DS, Milstein C . Mac-1: a macrophage differentiation antigen identified by monoclonal antibody Eur J Immunol 1979 9: 301–306

    Article  CAS  PubMed  Google Scholar 

  31. Ross G et al. Gene therapy in the United States: a five-year status report Hum Gene Ther 1996 7: 1781–1790

    Article  CAS  PubMed  Google Scholar 

  32. Robbins PD, Evans CH . Prospects for treating autoimmune and inflammatory diseases by gene therapy (editorial) Gene Therapy 1996 3: 187–189

    CAS  PubMed  Google Scholar 

  33. Mackensen A, Lindemann A, Mertelsmann R . Immunostimulatory cytokines in somatic cells and gene therapy of cancer Cytok Growth Factor Rev 1997 8: 119–128

    Article  CAS  Google Scholar 

  34. Bessis N et al. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 Eur J Immunol 1996 26: 2399–2403

    Article  CAS  PubMed  Google Scholar 

  35. Apparailly F et al. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis J Immunol 1998 160: 5213–5220

    CAS  PubMed  Google Scholar 

  36. Ma Y et al. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer J Immunol 1998 161: 1516–1524

    CAS  PubMed  Google Scholar 

  37. Whalen JD et al. Adenoviral transfer of the viral IL-10 gene peri-articularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws J Immunol 1999 162: 3625–3632

    CAS  PubMed  Google Scholar 

  38. Yang Y et al. Cellular immunity to viral antigens limits E1 deleted adenoviruses for gene therapy Proc Natl Acad Sci USA 1994 91: 4407–4411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Le CH, Nicolson AG, Morales A, Sewell KL . Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene Arthr Rheum 1997 40: 1662–1669

    Article  CAS  Google Scholar 

  40. Chun S, Daheshia M, Lee S, Rouse BT . Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: impliccation for gene therapy Cell Immunol 1999 194: 194–204

    Article  CAS  PubMed  Google Scholar 

  41. Song XY et al. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in streptococcal cell wall-induced arthritis model J Clin Invest 1998 101: 2615–2621

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Miossec P . Pro- and anti-inflammatory cytokine balance in rheumatoid arthritis Clin Exp Rheumatol 1995 13 (Suppl 12): S13–S16

    PubMed  Google Scholar 

  43. van Rooijen N, Sanders A . Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J Immunol Meth 1994 174: 83–93

    Article  CAS  Google Scholar 

  44. Muller CD, Schuber F . Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages Biochim Biophys Acta 1989 986: 97–105

    Article  CAS  PubMed  Google Scholar 

  45. Barratt G, Tenu JP, Yapo A, Petit JF . Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages Biochim Biophys Acta 1986 862: 153–164

    Article  CAS  PubMed  Google Scholar 

  46. Love WG, Amos N, Kellaway IW, Williams BD . Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis Ann Rheum Dis 1990 49: 611–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis (see comments) (published erratum appears in Nat Med 1995; 1: 272) Nat Med 1995 1: 39–46

    Article  CAS  PubMed  Google Scholar 

  48. Rogy MA et al. Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses J Exp Med 1995 181: 2289–2293

    Article  CAS  PubMed  Google Scholar 

  49. Stewart MJ et al. Gene transfer in vivo with DNA–liposome complexes: safety and acute toxicity in mice Hum Gene Ther 1992 3: 267–275

    Article  CAS  PubMed  Google Scholar 

  50. Yokoyama M, Zhang J, Whitton JL . DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity FEMS Immunol Med Microbiol 1996 14: 221–230

    Article  CAS  PubMed  Google Scholar 

  51. Nita I et al. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo Arthr Rheum 1996 39: 820–828

    Article  CAS  Google Scholar 

  52. Fife K et al. Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing Gene Therapy 1998 5: 614–620

    Article  CAS  PubMed  Google Scholar 

  53. Philip R et al. In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice J Biol Chem 1993 268: 16087–16090

    CAS  PubMed  Google Scholar 

  54. Liu Y et al. Cationic liposome-mediated intravenous gene delivery J Biol Chem 1995 270: 24864–24870

    Article  CAS  PubMed  Google Scholar 

  55. Allen TM, Hansen CB, Guo LS . Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection Biochim Biophys Acta 1993 1150: 9–16

    Article  CAS  PubMed  Google Scholar 

  56. de Waal Malefyt R et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 1991 174: 1209–1220

    Article  CAS  PubMed  Google Scholar 

  57. Ferguson TA, Dube P, Griffith TS . Regulation of contact hypersensitivity by interleukin 10 J Exp Med 1994 179: 1597–1604

    Article  CAS  PubMed  Google Scholar 

  58. Berg DJ et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses J Exp Med 1995 182: 99–108

    Article  CAS  PubMed  Google Scholar 

  59. Filion MC, Phillips NC . Anti-inflammatory activity of cationic lipids Br J Pharmacol 1997 122: 551–557

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Denham W et al. Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitis Ann Surg 1998 227: 812–820

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Chu CQ, Londei M . Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs J Immunol 1996 157: 2685–2689

    CAS  PubMed  Google Scholar 

  62. Stasiuk LM, Abehsira Amar O, Fournier C . Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen Cell Immunol 1996 173: 269–275

    Article  CAS  PubMed  Google Scholar 

  63. Wicks IP et al. Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy Hum Gene Ther 1995 6: 317–323

    Article  CAS  PubMed  Google Scholar 

  64. Alton EW et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice (published erratum appears in Nat Genet 1993 5: 312: Nat Genet 1993 5: 135–142

    Article  Google Scholar 

  65. Miller EJ . Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin Biochemistry 1972 11: 4903–4909

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Medical Research Council.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fellowes, R., Etheridge, C., Coade, S. et al. Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther 7, 967–977 (2000). https://doi.org/10.1038/sj.gt.3301165

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301165

Keywords

Search

Quick links